Tubulin dynamics can serve as a potential biomarker for assessing the efficacy and toxicity of drugs. Changes in the expression levels or post-translational modifications of tubulin can indicate cellular responses to treatment and provide insights into drug resistance mechanisms. Monitoring these changes can aid in the development of personalized therapeutic approaches and in the identification of predictive biomarkers for treatment outcomes.
